Business Economy


JB Pharma net up 16 percent to Rs 175 crore in Q2

New Delhi, Nov 6 (UNI) JB Chemicals & Pharmaceuticals Limited (JB Pharma) on Wednesday announced second quarter (July-September) financial performance and said its Profit After Tax grew 16 percent y-o-y to Rs 175 crore versus Rs 151 crore in the same quarter of last financial year.
JB Pharma recorded Revenue of Rs 1001 crore in the second quarter of FY25 registering growth of 13 percent from Rs 882 crores in Q2 FY24, the company said in a release.
Commenting on the financial results, Nikhil Chopra, CEO and Whole time Director, JB Pharma mentioned, “We maintained a healthy pace of growth in Q2, achieving Rs 1,000 crore revenue for the quarter. EBITDA margins at 28 percent are at the higher end of our guidance range, given a favourable product mix and cost optimization initiatives.”
JB’s domestic business continued to out-perform the market with all our major brands posting strong growth. The company has steadily driven strong volume growth for its large brands, including the acquired portfolios.
“On the international front, our formulations business performed well in Q2 and CDMO division growth will pick up in H2 as we come out of a seasonally muted Q2. JB has consistently delivered a strong revenue and margin growth. We are confident of maintaining this positive traction towards our operating and strategic goals for both this year and beyond. As we chart our future, we remain focused on making the organisation progressive and future ready,” Chopra added.
For the first six months of fiscal 2024-25, the company said that it recorded revenue of Rs 2005 crore as compared to Rs 1778 crores, registering growth of 13 percent. Profit after Tax grew 20 percent to Rs 351 crore as against Rs 293 crore in H1 FY24.
UNI SKB CS1920
More News

Market valuation of 5 of top 10 firms surges by over Rs 72,000 cr

07 Dec 2025 | 11:53 PM

New Delhi, Dec 7 (UNI) The market valuation of five of the top-10 most valued firms surged by Rs 72,284.74 crore last week, as per the data with the depositories. Tata Consultancy Services (TCS) and Infosys emerged as the biggest winners.

see more..

Singareni subsidiary companies to run profitably: Coal Ministry

07 Dec 2025 | 8:03 PM

Hyderabad, Dec 7 (UNI) As part of Singareni Company’s business expansion activities, and in view of entering the Green Energy and Critical Minerals sectors, the company has reserved names for the establishment of two new subsidiary companies.

see more..

Indian EPC sector strong in hiring activity: Study

06 Dec 2025 | 11:14 PM

Chennai, Dec 6 (UNI) India’s Engineering, Procurement, and Construction (EPC) sector is witnessing one of its strongest periods of hiring activity in recent years, with hiring demand surging 51 per cent since 2020, reveals CIEL HR’s EPC Sector Talent Study, 2025. .

see more..

RBI’s rate cut sets pro-growth tone as Inflation outlook softens sharply: SBI

06 Dec 2025 | 8:23 PM

New Delhi, Dec 6 (UNI) The Reserve Bank of India’s latest move to cut the repo rate by 25 basis points to 5.25 per cent reflects a clear commitment to support growth at a time when inflation is easing sharply and global uncertainties are rising, SBI said in its Ecowrap report.

see more..

India should launch National Satellite Connectivity Mission: SIA-India

06 Dec 2025 | 3:47 PM

Chennai, Dec 6 (UNI) Space Industry Association of India (SIA-India) SIA-India has called for the launch of a National Satellite Connectivity Mission (NSCM) to ensure uninterrupted digital governance and public service continuity in about 40,000 Gram Panchayats where terrestrial links repeatedly fail due to topographical challenges, multi-week outage cycles, and chronic disaster exposure. .

see more..